ACORN CAPITAL ADVISORS, LLC URGN Holdings History
Number of Shares
1.52 Mil
Current Holdings Value*
$16.77 Mil
% of Portfolio
11.18%
Total Estimate Gain
$5.02 Mil
% of Total Estimate Gain
27.68%
ACORN CAPITAL ADVISORS, LLC's UroGen Pharma Ltd Holding Summary
As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 1.52 Mil shares of UroGen Pharma Ltd(URGN), totaling $16.77 Mil. This investment constitutes 11.18% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 3.29% of the outstanding UroGen Pharma Ltd(URGN) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and URGN's current price of $15.27, ACORN CAPITAL ADVISORS, LLC's estimated gain on his URGN holdings is $5.02 Mil, reflecting a 27.68% gain to date.
ACORN CAPITAL ADVISORS, LLC URGN ($15.27) Holding Chart
ACORN CAPITAL ADVISORS, LLC URGN ($15.27) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1